A. Zlatareva

A Cross-Country Comparison of Reimbursed Orphan Medicines in Bulgaria, Greece and Romania

A. Stoimenova, M. Kamusheva, G. Petrova, 2013 .

ANALYSIS OF THE PUBLIC FUNDS SPENT FOR ANTI-CANCER DRUGS IN BULGARIA

A. Zlatareva, 2015 .

BENEFITS AND RISKS IN CONDUCTING OF CLINICAL TRIALS OF DRUGS IN HUMAN MEDICINE

A. Zlatareva, 2015 .

Pharmaceutical policy and public health in the eu candidate countries of the Western Balkans region

A. Zlatareva, B. Brankov, 2021, Health Economics and Management.

ANALYSIS OF ACCESS TO ORPHAN DRUGS IN FIVE NEIGHBORING EUROPEAN COUNTRIES - BULGARIA, GREECE, MACEDONIA, ROMANIA, AND SERBIA

M. Kamusheva, A. Zlatareva, Georgi, 2013 .

Chronic Myeloid Leukemia in Bulgaria in the New Millennium: Identification of Directions for Improvement in Management and Outcomes Reporting

A. Yordanov, V. Shivarov, D. Grigorova, 2024, Hemato.